Team (TISI) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Revenue increased 8.5% year-over-year to $248.0 million in Q2 2025, driven by strong IHT segment growth and higher turnaround and callout activity in the U.S. and Canada.
Gross margin rose 7.1% to $68.1 million; Adjusted EBITDA grew 12.4% to $24.5 million, representing 9.9% of revenue.
Net loss was $4.3 million ($0.95 per share), compared to a net loss of $2.8 million ($0.63 per share) in Q2 2024, impacted by higher non-core expenses and foreign currency losses.
Transformation and cost optimization initiatives yielded $10 million in expected annualized savings, with $6 million anticipated in the second half of 2025.
Leadership changes include the appointment of Dan Dawson (or Dolson) as EVP, Chief Strategy and Transformation Officer to accelerate transformation and margin improvement.
Financial highlights
Q2 2025 revenue: $248.0 million, up $19.4 million (8.5%) year-over-year.
Gross margin: $68.1 million (27.5% of revenue), up from $63.6 million (27.8%) in Q2 2024.
Adjusted EBITDA: $24.5 million (9.9% of revenue), up from $21.8 million (9.5%) in Q2 2024.
Adjusted net loss: $0.9 million, improved from $2.0 million in Q2 2024.
Free cash flow for Q2 2025 was negative $6.3 million; for the six months ended June 30, 2025, negative $36.3 million due to higher working capital usage.
Outlook and guidance
Targeting at least 15% year-over-year growth in adjusted EBITDA for full year 2025.
Expecting continued top-line growth and margin improvement in the second half of 2025, with full-year adjusted EBITDA margin target of at least 10%.
Anticipate $6 million in cost savings to be realized in the second half of 2025 from recent SG&A actions.
Management expects sufficient liquidity and working capital to fund operations and service debt for the next twelve months.
Full-year impact of transformation initiatives expected in 2026.
Latest events from Team
- 2026 meeting covers director elections, compensation, auditor, warrant issuance, and equity plan.TISI
Proxy filing24 Mar 2026 - Revenue, operating income, and adjusted EBITDA rose, margins improved, and debt was reduced.TISI
Q4 202513 Mar 2026 - Margins and cash flow improved in Q2 2024, with full-year growth and guidance reaffirmed.TISI
Q2 20242 Feb 2026 - Q3 2024 revenue and margins improved, but guidance was lowered amid ongoing liquidity and NYSE risks.TISI
Q3 202415 Jan 2026 - Margins and EBITDA improved in 2024, with refinancing extending debt maturities to 2030.TISI
Q4 202426 Dec 2025 - Registering 1.45M shares for resale post-$75M private placement, supporting recapitalization.TISI
Registration Filing16 Dec 2025 - Key votes include director elections, auditor ratification, and a charter amendment on director removal.TISI
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, pay, auditor ratification, and governance updates.TISI
Proxy Filing2 Dec 2025 - Flat Q1 revenue, $29.7M net loss, and refinancing set up at least 15% EBITDA growth for 2025.TISI
Q1 202525 Nov 2025